The Antitrust Prescription
The Antitrust Prescription covers antitrust and other economic issues affecting companies in the pharmaceutical industry. In this blog, Edgeworth’s experts provide legal practitioners and pharmaceutical company leaders with the latest economic insights and information impacting business in this constantly-evolving industry.
- Blog, 06.22.2026
In 2015, the Justice for United States Victims of State Sponsored Terrorism Act (“Act”) established the USVSST Fund. The Fund distributes compensation to victims of state sponsored terror and their families. Edgeworth was asked to provide an empirical analysis of payments from the United States Victims of State Sponsored Terrorism Fund.
- Blog, 04.22.2026
The role of PBMs in the pharmaceutical chain has been subject to debates in light of rising prescription drug spending.
- Blog, 04.09.2026
PBMs emerged in the 1960s, focusing on processing prescription drug claims. Before the establishment of PBMs, health plan beneficiaries paid cash for a prescription at the pharmacy, sent their receipt to the insurer, and then waited to be reimbursed.